Drawing for HONEYGLOW

USPTO serial 79417786

HONEYGLOW

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
RAMOS, STEPHEN NMN
Law office
TMO LAW OFFICE 134

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with HONEYGLOW?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicole M. Meyer

Nicole M. Meyer Dickinson Wright PLLC1825 Eye Street, N.W., Suite 900Washington, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical products, namely, chemical thickeners and perfluorinated chemical compounds sold as components for manufacturing cosmetic products, creams, lotions, soaps, perfumes and eau de Cologne, hair shampoos and hair emollients; preparations, namely, biological preparations, used as components in the manufacture of cosmetic products, creams, lotions, soaps, perfumes and eau de Cologne, hair shampoos and hair emollients; active chemical ingredients for use in the manufacture of cosmetics, moisturizing creams, creams, lotions, soaps, perfumes and eau de Cologne, hair shampoos and hair emollients; pharmaceutical products and ingredients, namely, plant derived additives and plant derived preparations for use in the manufacture of pharmaceuticals for treatment of viral and infectious diseases; active chemical ingredients for use in the manufacture of pharmaceuticals for treating viral and infectious diseasesACTIVE—
003Cosmetics; cosmetic preparations; facial moisturizers; body moisturizers; anti-aging creams; non-medicated skin serums; facial and body vaporizers, namely, facial mist sprays and body sprays for cosmetic use; non-medicated preparations for skin care; perfumes; skin creams; skin lotions, namely, for cosmetic use; bath foams; bath oils; hair shampoos; hair conditioners, namely, emollients; eaux de toilette; eau de Cologne; aftershave; after-shave balms; non-medicated soaps for the face and body; talcum powdersACTIVE—
005Pharmaceutical and nutraceutical preparations, namely, antioxidant, antimicrobial, dietary supplement, UV protectants, nutritional supplements plant extracts, polyphenol extracts, herbal extracts, serums, and vitamin preparation substances and ingredients, intended for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatologic, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and infectious diseases, blood diseases, pain, inflammation, sepsis, alopecia, diabetes, cancer, obesity and cognitive disorders and diseases and disorders of the immune system; pharmaceutical preparations and substances for cancer treatment; biological ingredients, namely, antioxidant, antimicrobial, dietary supplement, nutritional supplements plant extract, polyphenol extract, terpene extracts, herbal extracts, serum, vitamin preparations and preparations for cancer treatment; pharmaceutical products and ingredients, for the treatment of viral and infectious diseases; nutraceuticals for use as dietary supplements; nutraceuticals and pharmaceuticals for the treatment of cancer, obesity, diabetes and other diseases and disorders; biological preparations for the treatment of cancer, obesity, diabetes and other diseases and disorders; biological reagents for medical use; nutritional supplements; bio-medicines, namely, antioxidant, antimicrobial, anti-cancer bioactives, plant extract, polyphenol extract, terpene extracts, herbal extracts, serum, vitamin preparations, sunscreens, wound healing cream and serum, scar healing cream and serums; biomedical products, namely, antioxidant, antimicrobial, dietary supplement, nutritional supplements, extracts, serum, wound healing creams and patches, scar healing creams and serums, vitamin preparations; veterinary products, namely, antioxidant, antimicrobial, dietary supplement, nutritional supplements, extracts, serum, wound healing creams and patches, scar healing creams and serums, vitamin preparations; biological preparations for the treatment of cancer, obesity, diabetes and other diseases and disorders namely, for veterinary useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2026LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Sep 17, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 2, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 2, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 27, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 27, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 27, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 7, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 7, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 7, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 29, 2026RFNTREFUSAL PROCESSED BY IB—
Jan 7, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 8, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 8, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2025ATRVATTORNEY REVIEW COMPLETED—
Sep 8, 2025CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Jun 28, 2025RFNTREFUSAL PROCESSED BY IB—
Jun 6, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 6, 2025RFRRREFUSAL PROCESSED BY MPU—
Apr 4, 2025CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Apr 2, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 1, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2025DOCKASSIGNED TO EXAMINER—
Feb 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 28, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 27, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance